← Evidence map

ArticleEJHaem2023

Ars2-containing bispecific, Fab- and IgG1-format BAR-bodies to target DLBCL cells.

Maximilian Kiefer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36819155